February 9, 2026Rapamycin and Metabolic Effects: Blood Sugar, Cholesterol, and What to Monitor The pursuit of human longevity has transitioned from speculative…- February 25, 2026Rapamycin (Sirolimus / Rapamune), increasingly explored in longevity circles for its mTOR inhibition, can indeed trigger headaches in a subset…
- February 26, 2026Rapamycin inhibits mTORC1 rapidly but can disrupt mTORC2 with prolonged or high exposure, potentially leading to insulin resistance, immune suppression,…
- March 3, 2026Rapamycin shows promise in slowing or partially reversing epigenetic clocks in preclinical models like human skin cells and mice, however…
- March 10, 2026When integrating geroprotective compounds into a longevity protocol, individuals frequently encounter a paradoxical side effect: drug-induced dyslipidemia. Specifically, patients optimizing…
Free worldwide shipping
855-937-0672
